Li Kang Biomedical Co., Ltd. produces and sells pharmaceuticals, beauty products, and health food. It offers Chinese and Western medicines, nutritional supplements, beauty and skincare products, and daily necessities products. The company was formerly known as BAFO Technologies Corporation and changed its name to Li Kang Biomedical Co., Ltd. in September 2014. Li Kang Biomedical Co., Ltd. was founded in 1982 and is based in Tainan City, Taiwan.
Frequently asked questions
What sector does Li Kang Biomedical Co Ltd (6242) operate in?
Li Kang Biomedical Co Ltd belongs to the Consumer Staples sector and operates in the Travel Services industry.
What is Li Kang Biomedical Co Ltd (6242) current stock price?
As of the latest data, Li Kang Biomedical Co Ltd stock price is NT$34.00, with a previous close of NT$34.10. Li Kang Biomedical Co Ltd lost -NT$0.10 in the last trading session, representing a -0.29% loss.
What is Li Kang Biomedical Co Ltd (6242) current market capitalization?
Li Kang Biomedical Co Ltd market cap is approximately 1.08 billion.
What is Li Kang Biomedical Co Ltd (6242) Earnings Per Share (EPS)?
The trailing EPS is NT$2.62.
What is Li Kang Biomedical Co Ltd (6242) Price-to-Earnings (P/E) ratio?
Li Kang Biomedical Co Ltd current P/E ratio is 12.98.
Does Li Kang Biomedical Co Ltd (6242) pay dividends?
Yes. Li Kang Biomedical Co Ltd pays annual dividends with an annualized yield of 5.88% and an estimated annual payout of NT$2.00 per share.
When is the next ex-dividend date for Li Kang Biomedical Co Ltd (6242)?
The next ex-dividend date is scheduled for June 16, 2027.
What is Li Kang Biomedical Co Ltd (6242) beta (volatility) score?
Li Kang Biomedical Co Ltd has a beta of -0.063, indicating lower volatility than the overall market.
